Skip to Content

Development Services

Bora Biologics understands the complexities of bringing biologics to market. Our expertise in Analytical Development (AD), Formulation Development (FD), Mammalian Process Development, and Microbial Process Development, combined with cutting-edge technologies, ensures your project is in capable hands, from concept to First-in-Human (FIH) studies. Our tailored solutions ensure compliance, enhance product quality, and accelerate your time to market.

• Analytical Development and Validation
• Bioassays and Potency Testing
• Process Development (PD)
• Manufacturing Science and Technology (MSAT)
• Stability Studies
• Characterization of Biologics

Have a question?  Tell us what you need and one of our experienced colleagues will connect.

Connect with an Expert

image description image description

Why Choose Bora Biologics?

With a track record of successful development projects, Bora Biologics has established itself as a reliable partner in the biopharmaceutical industry. Our collaborations with leading companies highlight our commitment to and excellence in biologics development.

Comprehensive Expertise

Our team excels in developing robust assays tailored to your specific biologics, ensuring accurate measurement of potency and purity. We utilize advanced chromatography techniques and mass spectrometry for detailed characterization, providing the insights necessary for informed decision-making.

Proven Track Record

With over 45 biologics and biosimilars developed, over 100 successful cGMP batches delivered, a commercially approved biosimilar in the U.S. and Canada, and partnerships with leading pharmaceutical and biotech companies, we have established ourselves as a trusted partner in the biologics industry.

Mammalian and Microbial Expertise

We specialize in a diverse range of biologics, including fusion proteins, monoclonal antibodies, antibody derivatives, bispecific and trispecific antibodies, antibody-drug conjugates (ADCs), enzymes, and other innovative biologics. Our extensive experience in both mammalian and microbial systems enables us to deliver high-quality solutions tailored to your specific needs.

Regulatory Compliance

Our FDA-registered facility in the U.S. and our membership in PIC/S, ensure that we adhere to the highest global standards for drug substance production. This positions us to deliver quality biologics for clinical trials worldwide.

Reliable Method Validation
We employ industry-standard protocols for method validation, guaranteeing reproducibility and compliance with regulatory requirements. Consistency across production batches is achieved through stringent quality control measures and real-time analytics during production.

Innovative Formulation Solutions

Developing stable and effective formulations is our priority. We conduct rigorous stability studies in climate-controlled chambers and leverage formulation software for predictive modeling to enhance solubility and prevent aggregation, ensuring optimal performance in clinical settings.

Tailored Delivery Systems

We design and optimize delivery systems that safeguard product integrity. We also utilize automated liquid handling systems to improve efficiency and accuracy in our processes.

image description

Thought Leadership

Harnessing Biosimilar Experience

Our tailored analytical method development supports clients in navigating the complexities of biosimilars.

Comparative Analysis of Herceptin N-Glycans

Leveraging advanced techniques like HILIC-FLD and LC-MS/MS for quality assurance in biologics.

Characterization of PEGylation Sites

Utilizing mass spectrometry for precise characterization, enhancing product reliability.

Cell-based Potency Assays

Developing robust assays with Ready-to-Thaw cell banks to ensure consistent potency testing.

Working with Bora Biologics to develop our recombinant protein has been an excellent experience. Bora’s team has been fully engaged during the cell line and scale-up process and responsive to Technical and Quality requests. We hope to continue working with them to manufacture.

CEO of Q-Sera
image description image description

Integrated Allosteric Formulation Development Platform

Our cutting-edge Allosteric Formulation Development Platform enables fast, economical, and precise formulation development for a variety of biologics, including:

  • Monoclonal antibodies and their fragments
  • Antibody-Drug Conjugates (ADCs)
  • Cytokines, enzymes, and growth factors
  • Synthetic peptides and recombinant fusion proteins
  • Liposomes, lipid nanoparticles (LNPs), micelles, and polymers

Biophysical and Analytical Platforms

We employ advanced biophysical and analytical techniques to ensure comprehensive characterization of drug products:

  • Biophysical High Throughput Platform
    • Spectroscopy Techniques: Fluorescence, CD, NMR, ESR, FTIR, Raman, and Light Scattering (LS)
    • Biophysical Techniques: Differential Scanning Calorimetry (DSC), Analytical Ultracentrifugation (AUC), and Surface Plasmon Resonance (SPR)
  • Analytical Platform
    • A variety of HPLC-based methods (e.g., SEC, RP, CEX, HIC, HILIC), MALS, cIEF, CE-SDS, and mass spectrometry (MS)
    • Comprehensive assessments of osmolality, particle size (HIAC), morphological characterization (MFI), photostability, pH, viscosity, and protein concentration/solubility (A280/350)
    • Design of Experiments (DOE) and statistical analysis using JMP and GraphPad

Bora Biologics

the logical choice

Join the ranks of biopharma pioneers who trust us.
Explore how we minimize risks and accelerate your success.

Partner with us

Client-Centric

100% commitment to supporting your success

We have been the client, bringing multiple biologics from IND to BLA. Your needs and goals are at the forefront of our approach. By involving you in every step of the process, we ensure transparency and alignment, reducing the likelihood of misunderstandings and ensuring the outcome meets your expectations.

Experience

14 years developing & manufacturing biologics

We have honed our ability to navigate complexities. Our track record from concept to commercialization means we can apply best practices and lessons learned, ensuring smoother project execution.

Expertise

125 seasoned scientists & regulatory professionals

Our team exudes deep knowledge and specialized skills, with over 50% holding advanced degrees. This expertise allows us to foresee potential challenges and implement proactive solutions, reducing the likelihood of setbacks.

Commercial-Ready

US FDA registered GMP manufacturing facility

We focus on delivering solutions that are ready for market. With clinical to commercial scale facilities consistently meeting compliance standards, we ensure your project is primed for success, minimizing the risk of costly revisions or delays.

Allied

access to global CDMO resources

Our partnership with Bora Pharmaceuticals provides additional resources and insights. This network enables us to leverage shared knowledge and expertise, further mitigating risks and accelerating the overall success of your project.